BioCardia, Inc. (BCDA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 700K 1.4M 2.1M Q1 '21: 153K Q2 '21: 195K Q3 '21: 982K Q4 '21: 1M Q1 '22: 1M Q2 '22: 1.9M Q3 '22: 1.3M Q4 '22: 1.4M Q1 '23: 1.4M Q2 '23: 425K Q3 '23: 570K Q4 '23: 477K Q1 '24: 468K Q2 '24: 428K Q3 '24: 71K Q4 '24: 58K Q1 '25: 3K Q2 '25: 0 Q3 '25: 0 Q4 '25: 0 Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Gross Profit TTM

0 50K 100K 150K Q4 '10: 0 Q1 '11: 0 Q2 '11: 0 Q3 '11: 0 Q4 '11: 12K Q1 '12: 23K Q2 '12: 40K Q3 '12: 59K Q4 '12: 62K Q1 '13: 89K Q2 '13: 141K Q4 '10 Q2 '11 Q4 '11 Q2 '12 Q4 '12 Q2 '13

Operating Income TTM

-15M -10M -5M 0 5M 10M 15M Q3 '21: -12.7M Q4 '21: -12.6M Q1 '22: -13M Q2 '22: -12M Q3 '22: -12.3M Q4 '22: -11.9M Q1 '23: -12.1M Q2 '23: -13M Q3 '23: -12.6M Q4 '23: -11.6M Q1 '24: -10.4M Q2 '24: -8.6M Q3 '24: -7.8M Q4 '24: -8M Q1 '25: -8.5M Q2 '25: -8.9M Q3 '25: -8.6M Q4 '25: -8.3M Q1 '26: -7.8M Q2 '26: -7.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-15M -10M -5M 0 5M 10M 15M Q3 '21: -12.2M Q4 '21: -12.6M Q1 '22: -13M Q2 '22: -12M Q3 '22: -12.3M Q4 '22: -11.9M Q1 '23: -12.1M Q2 '23: -13M Q3 '23: -12.5M Q4 '23: -11.6M Q1 '24: -10.3M Q2 '24: -8.6M Q3 '24: -7.7M Q4 '24: -7.9M Q1 '25: -8.4M Q2 '25: -8.8M Q3 '25: -8.5M Q4 '25: -8.2M Q1 '26: -7.8M Q2 '26: -7.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 250K 500K 750K Q4 '12: 0 Q1 '13: 0 Q2 '13: 0 Q4 '17: 690K Q1 '18: 672K Q2 '18: 604K Q3 '18: 566K Q4 '18: 517K Q1 '19: 466K Q2 '19: 522K Q3 '19: 437K Q4 '19: 358K Q1 '20: 256K Q2 '20: 65K Q3 '20: 41K Q4 '20: 4K Q1 '21: 0 Q2 '21: 0 Q3 '21: 0 Q4 '21: 0 Q1 '13 Q1 '18 Q4 '18 Q3 '19 Q2 '20 Q1 '21 Q4 '21

Operating Cash Flow TTM

-12M -8M -4M 0 4M 8M 12M Q3 '21: -10.8M Q4 '21: -10.4M Q1 '22: -11.4M Q2 '22: -11.2M Q3 '22: -10.5M Q4 '22: -10.6M Q1 '23: -10.2M Q2 '23: -10.7M Q3 '23: -11.1M Q4 '23: -10M Q1 '24: -8.9M Q2 '24: -7.1M Q3 '24: -7.3M Q4 '24: -7.9M Q1 '25: -8M Q2 '25: -8.3M Q3 '25: -7.4M Q4 '25: -7.4M Q1 '26: -7.5M Q2 '26: -7.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-12M -8M -4M 0 4M 8M 12M Q3 '21: -10.9M Q4 '21: -10.5M Q1 '22: -11.5M Q2 '22: -11.3M Q3 '22: -10.6M Q4 '22: -10.6M Q1 '23: -10.3M Q2 '23: -10.7M Q3 '23: -11.1M Q4 '23: -10M Q1 '24: -8.9M Q2 '24: -7.1M Q3 '24: -7.3M Q4 '24: -7.9M Q1 '25: -8M Q2 '25: -8.3M Q3 '25: -7.4M Q4 '25: -7.4M Q1 '26: -7.5M Q2 '26: -7.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 80M 160M 240M Q1 '16: 230.3M Q2 '16: 230.3M Q3 '16: 230.5M Q1 '21: 16.6M Q2 '21: 17M Q3 '21: 17.1M Q1 '22: 17.1M Q2 '22: 17.7M Q3 '22: 17.8M Q1 '23: 20.2M Q2 '23: 1.4M Q3 '23: 1.4M Q1 '24: 1.7M Q2 '24: 1.9M Q3 '24: 2.8M Q1 '25: 4.6M Q2 '25: 5.1M Q3 '25: 6.3M Q1 '26: 10.8M Q2 '26: 12.1M Q2 '16 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-7.50 -5.00 -2.50 0.00 2.50 5.00 7.50 Q3 '21: -0.69 Q4 '21: -0.75 Q1 '22: -0.76 Q2 '22: -0.70 Q3 '22: -0.71 Q4 '22: -0.66 Q1 '23: -0.64 Q2 '23: -3.02 Q3 '23: -4.64 Q4 '23: -5.80 Q1 '24: -6.98 Q2 '24: -5.34 Q3 '24: -4.16 Q4 '24: -3.09 Q1 '25: -2.33 Q2 '25: -1.85 Q3 '25: -1.48 Q4 '25: -1.29 Q1 '26: -0.91 Q2 '26: -0.64 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.